Old Web
English
Sign In
Acemap
>
authorDetail
>
George Zhijian Chen
George Zhijian Chen
AstraZeneca
Medicine
Internal medicine
Osimertinib
Pathology
Oncology
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OA10.07 Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer patients: Analysis from AURA17 Trial
2018
Journal of Thoracic Oncology
C. Zhou
Min Hu
X. Zhu
Sun Y
Xuesong Lu
Jia Wang
Mengzhao Wang
Ying Cheng
Yan Chen
Yang Zhao
Yuankai Shi
Yanrong Lu
M. Shi
Helong Zhang
X Huang
Z. Wang
Z Ding
H Li
George Zhijian Chen
Y. Wu
Show All
Source
Cite
Save
Citations (5)
Identification of osimertinib resistance mechanisms in Chinese NSCLC patients: Analysis from AURA17 trial.
2018
Journal of Clinical Oncology
Min Hu
Yi-Long Wu
Xuehua Zhu
Yun Sun
Xuesong Lu
Jia Wang
Mengzhao Wang
Ying Cheng
Yuan Chen
Yanqiu Zhao
Yuankai Shi
You Lu
Meiqi Shi
Helong Zhang
Xiangning Huang
Zhijie Ding
George Zhijian Chen
Caicun Zhou
Show All
Source
Cite
Save
Citations (2)
Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions
2018
Journal of Gastroenterology and Hepatology
Yunsheng Yang
Jingyuan Fang
Xiaozhong Guo
Ning Dai
Xizhong Shen
Youlin Yang
Jing Sun
Bal R. Bhandari
David S. Reasner
Jacquelyn A. Cronin
Mark G. Currie
Jeffrey M. Johnston
Peter Zeng
Niwat Montreewasuwat
George Zhijian Chen
Sam Lim
Show All
Source
Cite
Save
Citations (22)
1